Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
36
ARZTY Quote, Financials, Valuation and Earnings
Last price:
$0.86
Seasonality move
:
-6.52%
Day range:
$0.86 - $0.86
52-week range:
$0.80 - $1.00
Dividend yield:
0%
P/E ratio:
20.02x
P/S ratio:
0.74x
P/B ratio:
2.12x
Volume:
--
Avg. volume:
287
1-year change:
-1.44%
Market cap:
$1.7B
Revenue:
$3.3B
EPS (TTM):
$0.04
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $3.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 47.13% | |
| Cost of Revenues | -- | -- | -- | -- | $2.7B | |
| Gross Profit | -- | -- | -- | -- | $642.5M | |
| Gross Profit Margin | -- | -- | -- | -- | 19.49% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $404.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | $404.6M | |
| Operating Income | -- | -- | -- | -- | $238M | |
| Net Interest Expenses | -- | -- | -- | -- | $38.9M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $199.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $25.3M | |
| Net Income to Company | -- | -- | -- | -- | $173.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $173.8M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $0.05 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $0.05 | |
| Weighted Average Basic Share | -- | -- | -- | -- | $2B | |
| Weighted Average Diluted Share | -- | -- | -- | -- | $2B | |
| EBITDA | -- | -- | -- | -- | $453.1M | |
| EBIT | -- | -- | -- | -- | $257.1M | |
| Revenue (Reported) | -- | -- | -- | -- | $3.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | $238M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $257.1M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $2.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | $1.9B | |
| Gross Profit | -- | -- | -- | -- | $472.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $294.8M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | $294.8M | |
| Operating Income | -- | -- | -- | -- | $177.6M | |
| Net Interest Expenses | -- | -- | -- | -- | $32.4M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $145.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $16.8M | |
| Net Income to Company | -- | -- | -- | -- | $128.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $128.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $0.04 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $0.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | $337M | |
| EBIT | -- | -- | -- | -- | $198M | |
| Revenue (Reported) | -- | -- | -- | -- | $2.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | $177.6M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $198M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | 2025-01-08 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $114.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $114.1M | |
| Inventory | -- | -- | -- | -- | $138.6M | |
| Prepaid Expenses | -- | -- | -- | -- | $20.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | -- | $429.2M | |
| Property Plant And Equipment | -- | -- | -- | -- | $921.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | $615.4M | |
| Other Intangibles | -- | -- | -- | -- | $105.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | $2.1B | |
| Accounts Payable | -- | -- | -- | -- | $239.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $31.5M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $598.6M | |
| Long-Term Debt | -- | -- | -- | -- | $518.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $1.4B | |
| Common Stock | -- | -- | -- | -- | $18.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | $772.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $772.2M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $2.1B | |
| Cash and Short Terms | -- | -- | -- | -- | $114.9M | |
| Total Debt | -- | -- | -- | -- | $518.2M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $95.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $181.9M | |
| Inventory | -- | -- | -- | -- | $130.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | -- | $411.3M | |
| Property Plant And Equipment | -- | -- | -- | -- | $887.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | $587M | |
| Other Intangibles | -- | -- | -- | -- | $95.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | $2B | |
| Accounts Payable | -- | -- | -- | -- | $455.7M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $579M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $1.2B | |
| Common Stock | -- | -- | -- | -- | $18.2M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $800.7M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $2B | |
| Cash and Short Terms | -- | -- | -- | -- | $95.5M | |
| Total Debt | -- | -- | -- | -- | $558.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $173.8M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $196M | |
| Stock-Based Compensation | -- | -- | -- | -- | $2.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$17.9M | |
| Change in Inventories | -- | -- | -- | -- | -$6.4M | |
| Cash From Operations | -- | -- | -- | -- | $365.9M | |
| Capital Expenditures | -- | -- | -- | -- | $99.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -$866.1K | |
| Cash From Investing | -- | -- | -- | -- | -$95.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $146M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$93.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$5.5M | |
| Other Financing Activities | -- | -- | -- | -- | -$417.8M | |
| Cash From Financing | -- | -- | -- | -- | -$419.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $266.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$149M | |
| Ending Cash (CF) | -- | -- | -- | -- | $112.5M | |
| Levered Free Cash Flow | -- | -- | -- | -- | $266.5M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | $128.5M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $139.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | $5.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$17.9M | |
| Change in Inventories | -- | -- | -- | -- | $12.1M | |
| Cash From Operations | -- | -- | -- | -- | $298.7M | |
| Capital Expenditures | -- | -- | -- | -- | $83.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -$218.6K | |
| Cash From Investing | -- | -- | -- | -- | -$79.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $163.9M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$141.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$276.1M | |
| Cash From Financing | -- | -- | -- | -- | -$292.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$77M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | $215.5M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | 2025-01-08 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get ARZTY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARZTY
Sector
P/E ratio
20.02x
17.67x
PEG ratio
--
0.34x
P/B ratio
2.12x
1.65x
Price / LTM sales
0.74x
0.67x
Growth Metrics
ARZTY
Sector
Revenue growth
--
0.27%
Earnings growth
--
-3.29%
Revenue (5-year growth)
-3.04%
4.25%
Earnings forecast
--
$0.32
Profitability
ARZTY
Sector
Profitability FY 2023
$642.5M
$569.5M
Return on invested capital
9.24%
5.28%
Return on assets
6.03%
3.53%
Return on equity
14.22%
8.17%
Earnings Date
Last Earnings Date
Aug
12
Next Earnings Date
Mar
20
Estimated Next Earnings Date
Nov
11
Balance Sheet
ARZTY
Sector
Total cash
$95.5M
$152.4M
Short term investments
--
$53.7M
Total assets
$2.1B
$1.8B
Long term debt
$558.8M
$138.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
